UK to revise Pfizer vaccine in shortest time possible - expert

Monday, 23. November 2020 13:08

British Medicines and Healthcare Products Regulatory Agency (MHRA) will review the vaccine candidate against COVID-19 developed by Pfizer Inc. and BioNTech SE in the shortest time possible, its Chief Executive Dr. June Raine said on Monday.

"It is our job now to rigorously assess these data and the evidence submitted on the vaccine's safety, quality, and effectiveness," Dr. Raine explained. "As we have received this data through a rolling review, we have already started our analysis."

Earlier this month, it was reported the United Kingdom would approve Pfizer and BioNTech's vaccine before the United States, with the National Health Service (NHS) allegedly being told that inoculation could begin as soon as December 1.

Related Links: BioNTech SEPfizer Inc.
Breaking the News / JR